Status | Study |
Recruiting |
Study Name: A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-11-04 Interventions: Biological: PF-06252616 PF-062 |
Recruiting |
Study Name: Stem Cell Therapy in Muscular Dystrophy Condition: Muscular Dystrophy Date: 2014-09-12 Interventions: Biological: Stem Cell Intrathecal Autologous bone marrow mononuclear cell transplantation |
Completed |
Study Name: Stem Cell Therapy in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-09-12 Interventions: Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Withdrawn |
Study Name: Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol Condition: Muscular Dystrophies Date: 2013-06-27 Interventions: Drug: Drisapersen Drisapersen will be supplied as 3 millilitre (mL) vials containing 1mL sterile solutio |
Recruiting |
Study Name: Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. Condition: Muscular Dystrophy Duchenne Muscular Dyst Date: 2013-02-26 Interventions: Biological: Stem Cell Intralesional transfer of Autologous Stem cell (MNCs) per dose. 6 doses in 3 month |
Completed |
Study Name: Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy Condition: Muscular Dystrophy Duchenne Muscular Dyst Date: 2013-02-26 Interventions: Other: Intralesional/ Intravenous of Autologous Stem cells. Intralesional/ Intravenous of Autologous MNC |
Terminated |
Study Name: Heart Imaging in Children With Muscular Dystrophy Condition: Muscular Dystrophy Date: 2012-06-30 |
Withdrawn |
Study Name: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2012-05-21 Interventions: Biological: human umbilical cord mesenchymal stem cells rehabilitation therapy plus human umbilical cord |
Completed |
Study Name: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2011-04-12 Interventions: Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |
Active, not recruiting |
Study Name: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2010-08-17 Interventions: Drug: Epigallocatechin-Gallate |